Jahre (Archiv)

2000

Ausgaben

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Ausgabe Sup. 2 · Volume 108 · 2000 DOI: 10.1055/s-002-707

221

Schatz, H.; Massi-Benedetti, M.: Pioglitazone: From development to clinical practice

224

Tan, M. H.: How pioglitazone affects glucose and lipid metabolism

234

Eckland, D. A.; Danhof, M.: Clinical pharmacokinetics of pioglitazone

243

Göke, B.: Type 2 diabetes: Are current oral treatment options sufficient?

250

Buse, J. B.: Pioglitazone in the treatment of type 2 diabetes mellitus: U.S. clinical experience

256

Hanefeld, M.; Göke, B.: Combining pioglitazone with a sulphonylurea or metformin in the management of type 2 diabetes

267

Belcher, G.; Matthews, D. R.: Safety and tolerability of pioglitazone

274

Reaven, G. M.: Insulin resistance - how important is it to treat?